Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun;238(6):1226-1236.
doi: 10.1002/jcp.31029. Epub 2023 Apr 30.

Stellate cell in hepatic inflammation and acute injury

Affiliations
Review

Stellate cell in hepatic inflammation and acute injury

Richa Rani et al. J Cell Physiol. 2023 Jun.

Abstract

The perisinusoidal hepatic stellate cells (HSCs) have been investigated extensively for their role as the major fibrogenic cells during chronic liver injury. HSCs also produce numerous cytokines, chemokines, and growth mediators, and express cell adhesion molecules constitutively and in response to stimulants such as endotoxin (lipopolysaccharide). With this property and by interacting with resident and recruited immune and inflammatory cells, HSCs regulate hepatic immune homeostasis, inflammation, and acute injury. Indeed, experiments with HSC-depleted animal models and cocultures have provided evidence for the prominent role of HSCs in the initiation and progression of inflammation and acute liver damage due to various toxic agents. Thus HSCs and/or mediators derived thereof during acute liver damage may be considered as potential therapeutic targets.

Keywords: acute liver injury; cell death; hepatic stellate cell; hepatocyte.

PubMed Disclaimer

References

REFERENCES

    1. Bachmann, M., Waibler, Z., Pleli, T., Pfeilschifter, J., & Mühl, H. (2017). Type I interferon supports inducible nitric oxide synthase in murine hepatoma cells and hepatocytes and during experimental acetaminophen-induced liver damage. Frontiers in Immunology, 8, 890.
    1. Ballegeer, M., & Libert, C. (2016). Different cell types involved in mediating concanavalin A induced liver injury: A comprehensive overview. Journal of Gastroenterology & Hepatology Research, 1, 01.
    1. Bamboat, Z. M., Ocuin, L. M., Balachandran, V. P., Obaid, H., Plitas, G., & DeMatteo, R. P. (2010). Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. Journal of Clinical Investigation, 120(2), 559-569.
    1. Bernal, W., & McPhail, M. J. (2021). Acute liver failure. Journal of Hepatology, 74, 1489-1490.
    1. Boetticher, N. C., Peine, C. J., Kwo, P., Abrams, G. A., Patel, T., Aqel, B., Boardman, L., Gores, G. J., Harmsen, W. S., McClain, C. J., Kamath, P. S., & Shah, V. H. (2008). A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology, 135, 1953-1960.

Publication types

LinkOut - more resources